For nasal congestion and allergy relief.1
First OTC INS* for nasal allergy and nasal congestion in Egypt.2
Breath freely, unblock your nose with a nasal allergy spray that relieves your allergy symptoms all day long.1
*INS: Intranasal Spray.
In this page you will find information about:
Get the Nasacort AQ advantage
What is Nasacort AQ?
Nasacort AQ for 24 hrs is given as a spray in the nose to treat the nasal symptoms of allergic rhinitis in adults.1
Nasal allergy symptoms include:1
• Nasal congestion
• Sneezing
• Itching
• Stuffy or runny nose
It helps some people within the first day of treatment, however, for other people it may take 3 to 4 days to feel a relief.1
Nasacort AQ is taken once daily.1
Why Nasacort AQ?
- 94.6% of patients were suffering from nasal congestion before using Nasacort AQ compared with 1.7% of the patients after using Nasacort AQ during the second visit for check-up.4
- With Nasacort's special propellant aqueous feature, the liquid is sprayed gently, and equally with low pressure.1
- It forms an umbrella shape inside the nose mucosa.6
- Nasacort AQ is unscented1, and gentle on nasal mucosa.3
- Nasacort has a unique "Thixotropic Technology"6, which is the ability of the liquid to transform into a viscous form "Gel".7
- The viscosity of the "Gel" helps the product to stay where it is sprayed (in the Nostrils).6
How to use?
Instructions for use
Before first use, a new bottle must be primed.2 (See the insert leaflet for more instructions).
Step 11
Before using your nasal spray…
- Blow your nose gently to clear your nostrils.
- Shake the bottle gently before use.
Step 21
- Close one nostril with your finger.
- Hold the bottle upright and put the nozzle into the other nostril as far as you comfortably can.
Step 31
- Breathe in gently through your nose with your mouth closed.
- While you are doing this, press the nozzle to deliver one spray.
Step 41
- Then breathe out through your mouth.
- Repeat these steps if you have to spray again in the same nostril and for the other nostril.
WHERE TO BUY?
Frequently Asked Questions
-
It helps some people within the first day of treatment, however, for other people it may take 3 to 4 days to feel a relief.
-
The usual starting dose is (2 sprays for adults over 12 years) in each nostril each day (Once daily).
-
Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. This medicine only works if used regularly. It can take 3 to 4 days before you notice your symptoms getting better.
-
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription. This is because Nasacort AQ can affect the way some other medicines work. Also, some medicines can affect the way Nasacort AQ work.
Nasacort AQ 55 micrograms/dose, nasal spray suspension
triamcinolone acetonide
What Nasacort AQ is and what it is used for
Nasacort AQ contains a medicine called triamcinolone acetonide, which belongs to a group of medicines called corticosteroids, which means it is a type of steroids.
It is given as a spray in the nose to treat the nasal symptoms of allergic rhinitis in adults and children 2 years of age and over.
Nasal symptoms of allergy include sneezing, itching, and having a blocked, stuffy or runny nose.
These can be caused by things such as: animal fur or house dust mites. This type of allergy can happen at any time of the year and is called "Perennial Allergic Rhinitis"; pollen. This type of allergy, such as hay fever, can be caused by different pollens in different seasons of the year. This is called "Seasonal Allergic Rhinitis". This medicine only works if used on a regular basis, and it may not help your symptoms straight away. It helps some people within the first day of treatment. However, for other people, it may take 3 to 4 days to feel a relief.
What you need to know before you take Nasacort AQ
Contraindications:
Do not use Nasacort AQ if you are allergic to triamcinolone acetonide or any of the other ingredients of this medicine.
Warnings and precautions
Take special care with Nasacort AQ. Talk to your doctor or pharmacist before using Nasacort AQ: if you have any infection of the nose or throat that is not treated. If you get a fungal infection while using Nasacort, stop using the spray until the infection has been treated; if you have recently had a nose operation, or had an injury or ulcer in the nose; if you are being transferred from steroid injections or tablets to Nasacort AQ spray; if you have had glaucoma or cataracts; if you are not sure if any of the above apply to you, talk to your doctor or pharmacist before using this medicine.
Children (Under 2 years):
This medicine is not recommended for use in children under 2 years of age.
Pregnancy, breast-feeding, and fertility:
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines:
Nasacort AQ has no, or negligible influence on the ability to drive or use machines.
How much Nasacort AQ to use?
Adults and children (Over 12 years):
-The usual starting dose is 2 sprays in each nostril each day.
-Once the symptoms of allergy are under control, the dose may be lowered to 1 spray in each nostril each day.
Children (6 to 12 years):
-The usual dose is 1 spray in each nostril each day.
-If the symptoms do not go away, then the dose may be increased to 2 sprays in each nostril each day.
-The dose can then be lowered again to 1 spray in each nostril each day.
Children (2 to 5 years):
-The usual dose is 1 spray in each nostril each day.
Do not use Nasacort AQ for more than 3 months in children under 12 years old. An adult should help a young child use this medicine.
Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop using Nasacort AQ and see a doctor, or go to a hospital straight away if: you have an allergic reaction to Nasacort AQ.
The signs (frequency not known) may include: a rash (hives), itching, swallowing or breathing problems, swelling of your lips, face, throat or tongue.
Common side effects (may affect up to 1 in 10 people): runny nose, headache, sore throat and/or cough; nosebleeds; inflammation/irritation of the airways (bronchitis); heartburn or indigestion; flu-like symptoms (fever, muscle pain, weakness and/or fatigue); problems with teeth.
- Always read the full prescribing information.
- Healthcare professionals are asked to report any suspected adverse reactions to the Egyptian Pharmacovigilance Center (EPVC).
PV.followup@edaegypt.gov.eg, Hotline: 15301, www.edaegypt.gov.eg.
- Egyptian Drug Authority (EDA), Nasacort AQ leaflet approval date: 25/01/2021.
1- Egyptian Drug Authority (EDA), Nasacort AQ leaflet approval date: 25/01/2021.
2- Egyptian Drug Authority (EDA), Nasacort AQ OTC switch approval. Approval date: 26/04/2022.
3- Munk ZM, LaForce C, Furst JA, Simpson B, Feiss G, Smith JA. Efficacy and safety of triamcinolone acetonide aqueous nasal spray in patients with seasonal allergic rhinitis. Annals of Allergy, Asthma & Immunology. 1996 Oct 1;77(4):277-81.
4- Elsammaa M. Registry on assessing the quality of life improvement with triamcinolone in the treatment of moderate-to-severe persistent allergic rhinitis in egyptian patients. The Egyptian Journal of Otolaryngology. 2016 Oct;32(4):243-7.
5- Foo MY, Sawant N, Overholtzer E, Donovan MD. A simplified geometric model to predict nasal spray deposition in children and adults. AAPS PharmSciTech. 2018 Oct;19(7):2767-77.
6- Berridge MS, Heald DL, Muswick GJ, Leisure GP, Voelker KW, Miraldi F. Biodistribution and kinetics of nasal carbon-11-triamcinolone acetonide. Journal of Nuclear Medicine. 1998 Nov 1;39(11):1972-7.
7- Food and Drug Administration (FDA), Nasacort AQ label. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020468s033s034lbl.pdf. [Last accessed: 17/04/2023].
This Material is approved by EDA. Approval number: HF0253OA678/072023, Invalidation Date: 10/7/2024
Kindly report any online promotional, educational and awareness material not having this message to the General administration for regulation of marketing & advertising materials at: www.edaegypt.gov.eg
HF0253OA678/072023
10/7/2024
